VIF World 2025-Melanie Saville, Chief Scientific Officer, PATH, USA

Melanie Saville, Chief Scientific Officer at PATH, will be speaking at VIF World 2025. Dr. Saville will address the pressing challenges and opportunities in global vaccine development, focusing on innovative solutions to improve vaccine accessibility and equity in underserved populations.

PrevVIF World 2025-Ken Ishii, Director, International Vaccine Design Center; Professor, University of Tokyo, Japan

NextVIF World 2025-Diana Boraschi, Distinguished Professor, Shenzhen Institute of Advanced Technology, China

Share to：